OTCMKTS: HCYT · Delayed Price · USD
+0.0004 (2.05%)
Jul 5, 2022 11:36 AM - Market open

Total Valuation

H-CYTE has a market cap or net worth of $3.26 million. The enterprise value is $6.69 million.

Market Cap 3.26M
Enterprise Value 6.69M

Important Dates

The latest earnings date was Wednesday, May 11, 2022, before market open.

Last Earnings Date May 11, 2022
Ex-Dividend Date n/a

Share Statistics

H-CYTE has 163.38 million shares outstanding. The number of shares has increased by 29.26% in one year.

Shares Outstanding 163.38M
Shares Change (YoY) +29.26%
Shares Change (QoQ) +14.27%
Owned by Insiders (%) 47.78%
Owned by Institutions (%) n/a
Float 4.98M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.02
PB Ratio n/a
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 4.14
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 0.04, with a Debt / Equity ratio of n/a.

Current Ratio 0.04
Quick Ratio 0.04
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -481.00%
Return on Capital (ROIC) n/a
Revenue Per Employee $201,864
Profits Per Employee -$910,427
Employee Count 8
Asset Turnover 1.62
Inventory Turnover n/a


Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -73.04% in the last 52 weeks. The beta is 1.53, so H-CYTE's price volatility has been higher than the market average.

Beta (1Y) 1.53
52-Week Price Change -73.04%
50-Day Moving Average 0.02
200-Day Moving Average 0.04
Average Volume (30 Days) 47

Short Selling Information

The latest short interest is 253,311, so 0.16% of the outstanding shares have been sold short.

Short Interest 253,311
Short % of Shares Out 0.16%
Short % of Float 5.08%
Short Ratio (days to cover) 5.33

Income Statement

In the last 12 months, H-CYTE had revenue of $1.61 million and -7.28 million in losses. Earnings per share was -$0.05.

Revenue 1.61M
Gross Profit 906,813
Operating Income -5.29M
Net Income -4.80M
Net Income Common -7.28M
EBIT -4.62M
Earnings Per Share (EPS) -$0.05
Full Income Statement

Balance Sheet

The company has $95,172 in cash and $3.52 million in debt, giving a net cash position of -$3.43 million or -$0.02 per share.

Cash & Cash Equivalents 95,172
Total Debt 3.52M
Net Cash -3.43M
Net Cash Per Share -$0.02
Book Value -4.66M
Book Value Per Share -0.03
Working Capital -4.72M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$4.81 million and capital expenditures -$7,830, giving a free cash flow of -$4.82 million.

Operating Cash Flow -4.81M
Capital Expenditures -7,830
Free Cash Flow -4.82M
FCF Per Share n/a
Full Cash Flow Statement


Gross margin is 56.15%, with operating and profit margins of -327.30% and -451.01%.

Gross Margin 56.15%
Operating Margin -327.30%
Pretax Margin n/a
Profit Margin -451.01%
EBITDA Margin -285.26%
EBIT Margin -286.24%
FCF Margin -298.32%

Dividends & Yields

H-CYTE does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Earnings Yield -223.46%
FCF Yield -147.81%
Dividend Growth (YoY) n/a
Payout Ratio n/a
Buyback Yield -30.72%
Shareholder Yield -30.72%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus Sell
Analyst Count 6
Stock Forecasts

Stock Splits

The last stock split was on June 13, 2022. It was a reverse split with a ratio of 1:1000.

Last Split Date Jun 13, 2022
Split Type Reverse
Split Ratio 1:1000